Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Nutritional interventions can help restore balance in male health by targeting oxidative stress and hormonal issues.

The new skin model can predict how chemicals might cause skin allergies.

MicroRNAs could lead to new treatments for skin diseases, but more research is needed.

PCOS is linked to low-grade chronic inflammation.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

New research suggests treating hair loss should focus on common inflammation rather than individual molecules.

Immune system issues may contribute to female pattern hair loss.

Personalized medicine and new technologies offer promising strategies for better skin disease treatments.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Regenerative medicine may offer long-lasting relief for chronic pain and neuro-degenerative conditions.

Scalp microbiota changes may be linked to inflammation in Alopecia Areata.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The study concluded that the developed models are effective for studying hair growth mechanisms and testing new treatments.

Stress and PCOS together may increase depression and anxiety-like behaviors.

Shifting attention can reduce physical pain.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

New therapies are being developed that target integrin pathways to treat various diseases.

SII is a useful and affordable tool to assess and monitor alopecia areata.